Insulin-like growth factor-I in men with idiopathic osteoporosis

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 9, 1997, Pages 2799-2805

  Kurland, Etah S ^a   Rosen, Clifford J ^b   Cosman, Felicia ^a,e   Mcmahon, Donald ^d   Chan, Fredriech ^c   Shane, Elizabeth ^a   Lindsay, Robert ^a,c   Dempster, David ^a,c   Bilezikian, John P ^a  

^a Columbia University ^*  (United States)

^b ST JOSEPH HOSPITAL   (United States)

^c HELEN HAYES HOSPITAL   (United States)

^d Division of Reproductive Endocrinology   (United States)

^e QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; CLINICAL ARTICLE; HUMAN; IDIOPATHIC DISEASE; LUMBAR SPINE; MALE; OSTEOPOROSIS; PRIORITY JOURNAL;

ADULT; AGED; BONE AND BONES; BONE DENSITY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUMBOSACRAL REGION; MALE; MIDDLE AGED; OSTEOPOROSIS; SPINE;

EID: 0030982438     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.9.2799     Document Type: Article

References (54)

1. Orwoll ES, Klein RF. 1995 Osteoporosis in men. Endocr Rev. 16:87-115.
2. Khosla S, Lufkin EG, Hodgson SF, Fitzpatrick LA, Melton LJ, III. 1994 Epidemiology and clinical features of osteoporosis in young individuals. Bone. 15:551-555.
3. Seeman E. 1995 The dilemma of osteoporosis in men. Am J Med. 98:[Suppl 2A:76-88S.
4. Jackson JA, Kleerekoper M. 1990 Osteoporosis in men: diagnosis, pathophysiology, and prevention. Medicine. 69:137-152.
5. Kelepouris N, Harper K, Gannon F, Kaplan F, Haddad JG. 1995 Severe osteoporosis in men. Ann Intern Med. 123:452-460.
6. Reed BY, Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CYC. 1995 Serum IGF-1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res. 10:1218-1224.
7. Canalis E. 1980 Effect of insulin-like growth factor 1 on DNA and protein synthesis in cultured rat calvaria. J Clin Invest. 66:709-719.
8. Jones JI, Clemmons DR. 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 16:3-32.
9. Rosen C, Donahue LR, Hunter SJ. 1994 Insulin-like growth factors and bone: the osteoporosis connection. Proc Soc Exp Biol Med. 206:83-102.
10. Rosen CJ, Johansson A. 1996 IGF's in the treatment of osteoporosis. In: Bilezikian JP, Raisz L, Rodan G, eds. Principles of bone biology. San Diego: Academic Press; 1099-1111.
11. Rosen CJ. 1994 IGFs and senescent bone: revisiting Ponce De Leon's fountain. J Cell Biochem. 58:360-365.
12. Ljunghall S, Johansson AG, Burnan P, Kampe O, Lindh E, Karlsson FA. 1992 Low plasma levels of insulin-like growth factor 1 (IGF) in male patients with idiopathic osteoporosis. J Intern Med. 232:59-64.
13. Nussbaum SR, Zahrandik RJ, Lavigne JR. 1987 Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 33:1364-1367.
14. Bouillon R, Herck EV, Jan L, Tan BK, Baelen HV, DeMoor P. 1984 Two direct (nonchromatographic) assays for 25-hydroxyvitamin D. Clin Chem. 30:1731.
15. Hollis BW. 1986 Assay of circulating 1,25-dihydroxy vitamin D involving a novel single cartridge extraction and purification procedure. Clin Chem. 32:2060-2063.
16. Bayer MF. 1987 Performance criteria for appropriate characterization of "highly sensitive" thyrotropin assays. Clin Chem. 33:630-631.
17. Ismail AAA. 1986 The role of testosterone measurements in the investigation of androgen disorders. Ann Clin Biochem. 23:113-34.
18. Kowalski A, Paul W. 1976 Clin Chem. 25:1152.
19. Seyedin SM, Kung VT, Daniloff YN, et al. 1993 Immunoassay for urinary pyridinoline: the new marker of bone resorption. 5:635-641.
20. Hanson DA, Weis MA, Bollen AM, Maslan SL, Singer F, Eyre DR. 1992 A specific immunoassay for monitoring human bone resorption: quantitation of type 1 collagen cross-linked N-telopeptides in urine. J Bone Miner Res. 7:1251-1258.
21. Gundberg CM, Wilson PS, Gallop PM, Parfitt AM. 1985 Determination of osteocalcin in human serum; results with two kits compared with those by a well-characterized assay. Clin Chem. 31:1720-1723.
22. Hill CS, Wolfert RL. 1989 The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase. Clin Chem Acta. 186:315.
23. Meikko J, Niemi S, Ristell L, Ristell J. 1990 Radioimmunoassay for the carboxyterminal propeptide of human type 1 procollagen (PICP). Clin Chem. 36:1328-1332.
24. Breier BH, Callaher BW, Gluckman PD. 1991 Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls. J Endocrinol. 128:347-357.
25. Grogean T, Verault D, Millard PS, et al. 1997 A comparative analysis of methods to measure IGF-1 in human serum. Endocrinol Metab. 4:109-114.
26. Genant HK, Grampp S, Gluer CC, et al. 1994 Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res. 9:1503-1514.
27. Recker RR. 1983 Bone histomorphometry techniques and interpretation. Boca Raton: CRC Press.
28. Meunier PJ, Bressot C. 1983 Endocrine influences on bone cells and bone remodeling evaluated by clinical histomorphometry. In: Parsons JA, ed. Endocrinology of calcium metabolism; 445-465.
29. Parfitt M, Drezner MK, Glorieux FH, et al. 1987 Bone histomorphometry: standardizaton of nomenclature, symbols, and units. J Bone Miner Res. 2:595-609.
30. Courpron P, Meunier P, Bressot C, Giroux JM. 1976 Amount of bone in the iliac crest biopsy. In: Meunier PJ, ed. Second international workshop on bone morphometry. Lyon: Societe de la Nouvelle Imprimerie Fournie Toulouse; 39-53.
31. Meunier P, Edouard C, Richard D, Laurent J. 1976 Histomorphometry of osteoid tissue. The hyperosteoidoses. In: Meunier PJ, ed. Second international workshop on bone morphometry. Lyon: Societe de la Nouvelle Imprimerie Fournie Toulouse; 249-262.
32. Meunier P, Edouard C, Courpron P. 1976 Morphometric analysis of trabecular resorption surfaces in normal iliac bone. In: Jaworski ZFG ed. Proc. First workshop on bone morphometry. Ottawa: University of Ottawa Press; 156-160.
33. Melsen F, Mosekilde L. 1978 Tetracyline double-labeling of iliac trabecular bone in 41 normal adults. Calc Tissue Res. 26:99.
34. Melsen F, Melsen B, Mosekilde L, Bergmann S. 1978 Histomorphometric analysis of normal bone from the iliac crest. Acta Pathol Microbiol Scand (A). 86:70-81.
35. Kanis JA, Melton JI, Christiansen C, Johnston CC, Khaltaev N. 1994 The diagnosis of osteoporosis. J Bone Miner Res. 9:(8):1137-1141.
36. Fazzalari NL. 1993 Trabecular microfracture. Calcif Tissue Int. 53 [Suppl] 1:5143-147.
37. Hayden JM, Mohan S, Baylink DJ. 1995 The insulin-like growth factor system and the coupling of formation to resorption. Bone. 17:(2):93S-98S.
38. Canalis E, McCarthy T, Centrella M. 1988 Growth factors and the regulation of bone remodeling. J Clin Invest. 81:277-281.
39. Bennett AE, Heinz WW, Riggs L, Hintz R. 1984 Insulin-like growth factors I and II: aging and bone density in women. J Clin Endocrinol Metab. 59:701-4.
40. De Vernejoul MC, Bielkoff J, Herve M, et al. 1983 Evidence for defective osteoblastic function: a role for alchohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop Rel Res. 179:107-115.
41. Jackson JA, Kleerekoper M, Parfit AM, Rao DS, Villanueva AR, Frame B. 1987 Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab. 65:53-58.
42. Canalis E, Centrella M, Burch W, McCarthy TL. 1989 Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest. 83:60-65.
43. Schmid C, Schlapfer I, Peter M, et al. 1994 Growth hormone and parathyroid hormone stimulate IGFBP-3 in rat osteoblasts. American Physiological Society. 267:E226-E233.
44. Wong MM, Rao LG, Ly H, et al. 1994 In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non-osteoporotic controls. Osteoporosis Int. 4:(1):21-31.
45. McCarthy TL, Centrella M, Canalis E. 1990 Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures. J Biol Chem. 265 No. 26:15353-15356.
46. Torring O, Firek AF, Heath H, III, Conover CA. 1991 Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-like cells through a adenosine 3′, 5′-monophosphate- dependent mechanism. Endocrinology. 128:1006-1014.
47. Blumsohn A, Eastell R. 1995 Age-related factors. In: Riggs BL, Melton LJ III, eds. Osteoporosis: etiology, diagnosis, and management, 2nd ed. Philadelphia: Lippincott-Raven:161-182.
48. Silverberg S, Shane E, De La Cruz L, Segre G, Clemens T, Bilezikian JP. 1989 Abnormalities in parathyroid hormone secretion and 1,25 dihydroxyvitamin D3 formation in women with osteoporosis. N Engl J Med. 320:277-281.
49. Rosen T, Hansson T, Granhed H, Szucs J, Bengtsson BA. 1993 Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol. 129:201-206.
50. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KKY. 1994 Diagnosis of growth-hormone deficiency in adults. Lancet. 343:1064-1068.
51. Toogood AA, O'Neill PA, Shalet SM. 1996 Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. J Clin Endocrinol Metab. 81:460-465.
52. Kurland E, Chan F, Vereault D, Rosen C, Bilezikian JP. 1996 Growth hormone axis in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I. J Bone Miner Res. 11:[Suppl ]:S327.
53. Korenman SG, Morley JE, Mooradian AD, et al. 1990 Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab. 71:963-969.
54. Pfeilschifter J, Scheidt-Nave C, Leidig-Bruckner G, et al. 1996 Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab. 81:2534-2540.